Answers are grounded in this paper and cite their sources.
Objective: To compare red blood cell parameters across high-performance liquid chromatography (HPLC)-based hemoglobinopathy categories at a Tertiary Care Centre in Bhopal. Methods: This observational study included 130 eligible participants evaluated at Gandhi Medical College, Bhopal, from February to July 2024. Seven hematological measurements were summarized by recorded diagnosis. Exploratory Kruskal-Wallis tests compared beta-thalassemia trait (BTT), beta-thalassemia major (BTM), sickle cell trait (SCT), and sickle cell disease (SCD), with Holm adjustment across seven outcomes. Dunn pairwise tests used adjustment across 42 comparisons. Complete blood count consistency was assessed by comparing recorded and calculated indices. Results: SCT accounted for 41 participants (31.5%), BTT for 35 (26.9%), SCD for 34 (26.2%), and BTM for six (4.6%). Across the four principal groups, all seven measurements differed at Holm-adjusted P<0.05 mean MCV was 68.13±10.96 fL in BTT and 81.03±11.23 fL in SCT. The median BTT-SCT difference was-12.0 fL (pointwise bootstrap 95% CI-17.9 to-8.8; adjusted P<0.001). Adjusted SCT-SCD comparisons yielded P values of 0.05 or greater. Complete blood count consistency review flagged 87 participants (66.9%). Conclusion: The recorded data demonstrate group-level hematological variation, with the clearest contrast between BTT and SCT. Measurement consistency flags, age heterogeneity, and mixed diagnostic terminology limit clinical interpretation and support source reconciliation and prospective validation before CBC-based classification is used clinically.
No takes yet. Share an insight, caveat, or question.
RAO et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: